Skip to main content
. 2017 Jun 16;10(1):22. doi: 10.1186/s40413-017-0152-5

Table 2.

Adverse events

Intervention group Control group
Related to ingestion of the study product Related to ingestion of the study product
No Yes Unclear No Yes Unclear
Urticaria 2 1
Eczema flares 2 1 5
Vomiting 1 2a 3
Abdominal Pain 1
Hospital Admission >24 h 1 2

avomiting in both cases was associated with reintroduction of study product after gastroenteritis